Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NASDAQ:INMD NASDAQ:MGRM NASDAQ:SSII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$21.42+1.5%$20.41$17.86▼$29.62$1.05B1.97400,006 shs134,078 shsINMDInMode$14.34+0.2%$13.84$12.72▼$16.74$907.63M1.97983,728 shs311,011 shsMGRMMonogram Orthopaedics$6.00$5.93$2.32▼$6.43$243.79M0.68253,414 shsN/ASSIISS Innovations International$3.91-3.5%$4.73$3.02▼$11.87$791.51MN/A80,530 shs28,031 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions0.00%-0.93%+8.71%-7.14%-16.07%INMDInMode0.00%+0.70%+4.50%-9.37%-1.10%MGRMMonogram Orthopaedics0.00%0.00%0.00%0.00%+107.61%SSIISS Innovations International0.00%-8.28%-20.20%+9.32%+398,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$21.42+1.5%$20.41$17.86▼$29.62$1.05B1.97400,006 shs134,078 shsINMDInMode$14.34+0.2%$13.84$12.72▼$16.74$907.63M1.97983,728 shs311,011 shsMGRMMonogram Orthopaedics$6.00$5.93$2.32▼$6.43$243.79M0.68253,414 shsN/ASSIISS Innovations International$3.91-3.5%$4.73$3.02▼$11.87$791.51MN/A80,530 shs28,031 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions0.00%-0.93%+8.71%-7.14%-16.07%INMDInMode0.00%+0.70%+4.50%-9.37%-1.10%MGRMMonogram Orthopaedics0.00%0.00%0.00%0.00%+107.61%SSIISS Innovations International0.00%-8.28%-20.20%+9.32%+398,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 2.80Moderate Buy$32.0049.43% UpsideINMDInMode 2.00Hold$17.2520.33% UpsideMGRMMonogram Orthopaedics 1.00SellN/AN/ASSIISS Innovations International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest MGRM, BLFS, INMD, and SSII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026SSIISS Innovations International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026BLFSBioLife Solutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)2/11/2026INMDInMode Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$17.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$96.21M10.88$0.23 per share92.63$7.72 per share2.77INMDInMode$370.49M2.45$1.48 per share9.66$10.78 per share1.33MGRMMonogram OrthopaedicsN/AN/AN/AN/A$0.42 per shareN/ASSIISS Innovations International$42.49M18.43N/AN/A$0.20 per share19.55Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$4.59M-$0.11N/A85.66N/A-4.50%1.71%1.54%5/7/2026 (Estimated)INMDInMode$93.83M$1.449.95N/AN/A25.33%14.52%12.88%5/6/2026 (Estimated)MGRMMonogram Orthopaedics-$16.33M-$0.50N/AN/AN/AN/A-126.82%-96.87%N/ASSIISS Innovations International-$12.13M-$0.06N/AN/AN/A-28.54%-30.23%-17.50%N/ALatest MGRM, BLFS, INMD, and SSII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026BLFSBioLife Solutions$0.01N/AN/AN/A$25.66 millionN/A5/6/2026Q1 2026INMDInMode$0.2974N/AN/AN/A$79.84 millionN/A3/10/2026Q4 2025SSIISS Innovations InternationalN/A-$0.01N/A-$0.01N/A$14.53 million2/10/2026Q4 2025INMDInMode$0.4167$0.46+$0.0433$0.42$104.64 million$103.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/ASSIISS Innovations InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife SolutionsN/A5.944.63INMDInModeN/A9.888.83MGRMMonogram OrthopaedicsN/A2.162.16SSIISS Innovations InternationalN/A1.861.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%INMDInMode68.04%MGRMMonogram Orthopaedics0.45%SSIISS Innovations InternationalN/AInsider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%INMDInMode6.92%MGRMMonogram Orthopaedics28.10%SSIISS Innovations InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44048.90 million47.82 millionOptionableINMDInMode48063.36 million58.98 millionOptionableMGRMMonogram Orthopaedics2840.63 million29.21 millionNot OptionableSSIISS Innovations International4200.23 millionN/AN/AMGRM, BLFS, INMD, and SSII HeadlinesRecent News About These CompaniesSS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic SystemMay 5 at 8:30 AM | globenewswire.comSS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to "Sell"May 2 at 1:08 AM | marketbeat.comShort Interest in SS Innovations International, Inc. (NASDAQ:SSII) Declines By 49.8%April 26, 2026 | marketbeat.comSS Innovations Showcases Next-Gen Robotic Surgery Platforms GloballyApril 25, 2026 | theglobeandmail.comPRISM MediaWire – Weekly Press Release Round Up – April 20 to April 24, 2026 – Top Financial & Corporate News HighlightsApril 24, 2026 | prismmediawire.comPSS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026April 23, 2026 | prismmediawire.comPSS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026April 23, 2026 | globenewswire.comSS Innovations International (NASDAQ:SSII) Shares Gap Down - Here's WhyApril 22, 2026 | marketbeat.comSS Innovations International (NASDAQ:SSII) Shares Gap Up - Time to Buy?April 13, 2026 | marketbeat.comSS Innovations: Progress Is Real, But I Still See Limited UpsideApril 9, 2026 | seekingalpha.comSS Innovations International (NASDAQ:SSII) Trading Down 8.2% - Should You Sell?April 8, 2026 | marketbeat.comSS Innovations International (NASDAQ:SSII) Stock Price Up 8.8% - Time to Buy?April 7, 2026 | marketbeat.comSS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026April 7, 2026 | prismmediawire.comPSS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026April 7, 2026 | globenewswire.comSS Innovations International Inc (SSII)April 3, 2026 | nasdaq.comSS Innovations International, Inc. (SSII) gains approvals for SSi Mantra in key emerging marketsApril 3, 2026 | msn.comSS Innovations Is A Compelling Surgical Robotics Growth PlayMarch 30, 2026 | seekingalpha.comSS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and KenyaMarch 30, 2026 | prismmediawire.comPSS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and KenyaMarch 30, 2026 | globenewswire.comWhy SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern DoubtsMarch 23, 2026 | finance.yahoo.comSS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the PhilippinesMarch 18, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGRM, BLFS, INMD, and SSII Company DescriptionsBioLife Solutions NASDAQ:BLFS$21.42 +0.33 (+1.54%) As of 02:46 PM Eastern This is a fair market value price provided by Massive. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.InMode NASDAQ:INMD$14.34 +0.03 (+0.17%) As of 02:46 PM Eastern This is a fair market value price provided by Massive. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Monogram Orthopaedics NASDAQ:MGRMMonogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.SS Innovations International NASDAQ:SSII$3.91 -0.14 (-3.46%) As of 02:46 PM Eastern This is a fair market value price provided by Massive. Learn more.AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas onsemi Stock Dips After Earnings: Why the Dip Is Buyable Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom Atomic Dividends: Big Tech's New Energy Bet Monolithic Power Systems: AI Stock Beat, Raised and Upgraded Post-Earnings Leading Insider Sales: April Activity Ramps in These Stocks The New Fed Chair Trade: Who Wins When Warsh Takes the Helm? A Prada Payday: Is AMC Back in Style? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
